
Prostate Cancer Studies Show Why Personalized Treatment, Trial Diversity Matter, Dorff Says
Studies involving prostate cancer presented during the recent American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) showed the importance of paying attention to each patient’s clinical features, along with diverse trial enrollment …